Ulf Landmesser

Interventional cardiologist / Cardiologist

Charité Universitätsmedizin Berlin - Berlin, Germany

Latest contributions

LAA occlusion vs. novel oral anticoagulation in atrial fibrillation

27 Jun 2020 – From PCR e-Course 2020

Learn which patients may benefit from LAA Occlusion (LAAO) vs. long term anticoagulation, and access the latest data of LAAO vs NOAC from a substantial cohort in a propensity score matched study to find out what impact it might have medium and longer term.

Videos included on...

LAA occlusion vs. novel oral anticoagulation